← Leaderboards
Xiao-Fang Yu
Johns Hopkins University
$15,220,244
Attributed
$17,447,094
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$17,447,094 · 14
By mechanism
R01$13,193,293 · 7
T32$2,309,326 · 1
R21$1,575,475 · 4
R56$369,000 · 1
P01$0 · 1
Top collaborators
- Peter C Agre5 shared
- Jay H. Bream5 shared
- Isabelle Coppens5 shared
- George Dimopoulos Dimopoulos5 shared
- Rhoel David Ramos Dinglasan5 shared
- Gregory E Glass5 shared
- Diane E Griffin5 shared
- J. Marie Hardwick5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Eric L Nuermberger$20,859,483
- Geraldine Seydoux$9,556,870
- Sean Lamonte Evans$84,032
- Sylvain Dore$11,107,719
- Kenrad E Nelson$2,831,844
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsClinical ResearchChinaIntravenous Drug AbuseHuman SubjectCommunicable Disease TransmissionViralVirus GeneticsHiv-1Human Immunodeficiency Virus 1Genetic StrainCytidine DeaminaseProteinsGenetic PolymorphismInsightDesignHeroinPathologic ProcessVirus LoadLongitudinal Human StudyMacrophageHost Organism InteractionComplexIntegration Host Factors
Grant awards (48)
Training: Molecular & Cellular Bases of Infectious Diseases$424,613
T32 · FY2014 · AI
Training: Molecular & Cellular Bases of Infectious Diseases$507,302
T32 · FY2013 · AI
Identification of novel anti-HIV inhibitors based on Vif-E3 activity$228,420
R21 · FY2013 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$499,422
T32 · FY2012 · AI
A novel allele influencing HIV infection among injection drug users$312,353
R01 · FY2012 · DA · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$450,573
T32 · FY2011 · AI
A novel allele influencing HIV infection among injection drug users$312,353
R01 · FY2011 · DA · contact PI
Identification and characterization of novel anti-HIV inhibitors$202,950
R21 · FY2011 · AI · contact PI
Training: Molecular & Cellular Bases of Infectious Diseases$427,416
T32 · FY2010 · AI
Role of Cul5 E3 Ubiquitin ligasae in HIV Vif function: A novel regulator$369,000
R56 · FY2010 · AI · contact PI
A novel allele influencing HIV infection among injection drug users$322,013
R01 · FY2010 · DA · contact PI
Identification and characterization of novel anti-HIV inhibitors$246,000
R21 · FY2010 · AI · contact PI
Novel Small Molecule Inhibitors of HIV$205,000
R21 · FY2010 · AI · contact PI
A novel allele influencing HIV infection among injection drug users$325,266
R01 · FY2009 · DA · contact PI
Novel Small Molecule Inhibitors of HIV$246,000
R21 · FY2009 · AI · contact PI
A novel allele influencing HIV infection among injection drug users$340,466
R01 · FY2008 · DA · contact PI
Role of Cul5 E3 ubiquitin ligase in HIV Vif function$304,164
R01 · FY2008 · AI · contact PI
Regulation of antiviral APOBEC3G and APOBEC3F by interferons$201,105
R21 · FY2008 · AI · contact PI
Implications of HIV in Low HCV Clearance in Chinese IDUs$610,488
R01 · FY2007 · DA · contact PI
Role of Cul5 E3 ubiquitin ligase in HIV Vif function$310,055
R01 · FY2007 · AI · contact PI
Regulation of antiviral APOBEC3G and APOBEC3F by interferons$246,000
R21 · FY2007 · AI · contact PI
Implications of HIV in Low HCV Clearance in Chinese IDUs$624,668
R01 · FY2006 · DA · contact PI
Role of Cul5 E3 ubiquitin ligasae in HIV Vif function$319,316
R01 · FY2006 · AI · contact PI
Implications of HIV in Low HCV Clearance in Chinese IDUs$645,519
R01 · FY2005 · DA
Role of Cul5 E3 ubiquitin ligasae in HIV Vif function$320,650
R01 · FY2005 · AI
Implications of HIV in Low HCV Clearance in Chinese IDUs$634,422
R01 · FY2004 · DA
VIRAL &HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS$544,609
R01 · FY2004 · DA
Role of Cul5 E3 ubiquitin ligase in HIV Vif function$312,713
R01 · FY2004 · AI
VIRAL &HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS$102,600
R01 · FY2004 · DA
VIRAL &HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS$652,167
R01 · FY2003 · DA
Implications of HIV in Low HCV Clearance in Chinese IDUs$634,171
R01 · FY2003 · DA
VIRAL DETERMINANTS OF DISEASE PROGRESSION IN HIV+ IDUS$313,820
R01 · FY2003 · DA
VIRAL &HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS$90,195
R01 · FY2003 · DA
BEHAVIORAL AND VIROLOGIC FEATURES OF HIV+ IDUS IN CHINA$604,232
R01 · FY2002 · DA
VIRAL &HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS$539,206
R01 · FY2002 · DA
VIRAL DETERMINANTS OF DISEASE PROGRESSION IN HIV+ IDUS$304,677
R01 · FY2002 · DA
VIRAL &HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS$121,252
R01 · FY2002 · DA
Cellular Immune Responses to DNA and Recombinant VEE$0
P01 · FY2002 · AI
BEHAVIORAL AND VIROLOGIC FEATURES OF HIV+ IDUS IN CHINA$589,516
R01 · FY2001 · DA
VIRAL &HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS$523,501
R01 · FY2001 · DA
EVALUATION OF HIV GAG DNA VACCINE TO MAX T HELPER/CTL$303,404
R01 · FY2001 · AI
VIRAL DETERMINANTS OF DISEASE PROGRESSION IN HIV+ IDUS$273,205
R01 · FY2001 · DA
Cellular Immune Responses to DNA and Recombinant VEE$0
P01 · FY2001 · AI
BEHAVIORAL AND VIROLOGIC FEATURES OF HIV+ IDUS IN CHINA$592,555
R01 · FY2000 · DA
VIRAL AND HOST FACTORS ON HIV TRANSMISSION/PATHOGENESIS$525,203
R01 · FY2000 · DA
EVALUATION OF HIV GAG DNA VACCINE TO MAX T HELPER/CTL$370,194
R01 · FY2000 · AI
VIRAL DETERMINANTS OF DISEASE PROGRESSION IN HIV+ IDUS$265,650
R01 · FY2000 · DA
BEHAVIORAL AND VIROLOGIC FEATURES OF HIV+ IDUS IN CHINA$148,690
R01 · FY2000 · DA